combined estrogen plus bisphosphonate
Jump to navigation
Jump to search
Introduction
Study:
- randomized trial
- 373 women age 65-90 years
- 3 years duration
- 4 groups
- alendronate
- HRT
- alendronate plus HRT
- double placebo
Results: (after 3 years)
- increased bone mineral density at hip & spine in 3 treatment groups relative to placebo
- combination therapy best for increasing bone mineral density at both hip & spine
- alendronate better than HRT for increasing bone mineral density at hip but not in spine
- effects not additive
- only adverse effects related to HRT
More general terms
References
- ↑ Journal Watch 23(13):102, 2003
Greenspan SL et al, Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: a randomized controlled trial. JAMA 289: 2525, 2003 PMID: https://www.ncbi.nlm.nih.gov/pubmed/12759324